文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

线上机械性吸呼气辅助排痰在有创机械通气患者中的临床效果观察

[An observational study on the clinical effects of in-line mechanical in-exsufflation in mechanical ventilated patients].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025-01-01
一句话结论有创机械通气患者使用线上机械性吸呼气辅助排痰可改善痰液性状、氧合与呼吸力学,患者耐受良好且无治疗相关不良事件。

本研究为前瞻性观察性研究,纳入2022年4月至2023年5月中山大学附属第一医院重症医学科13例有创机械通气并接受线上机械性吸呼气辅助排痰的患者,均为男性、呼吸衰竭,主要病因为颈髓损伤/高位截瘫(38.46%)。使用前痰液黏度III级者占38.46%(5/13),使用7天后降至22.22%(2/9)。随使用时间延长,临床肺部感染评分(CPIS)日均下降0.5分(P<0.01),氧合指数日均升高23.3 mmHg、动脉血氧分压日均升高12.6 mmHg(均P<0.01)。使用7天后呼吸系统顺应性(Cst)较基线显著升高、气道阻力与驱动压(DP)显著下降(均P<0.01),治疗期间未见新发肺不张,心率、收缩压、舒张压及平均动脉压无实质性变化,无治疗相关不良事件。

要点

  • 13例有创机械通气患者使用线上机械性吸呼气辅助排痰,均为男性、呼吸衰竭,主要病因为颈髓损伤/高位截瘫(38.46%)。
  • 使用7天后痰液黏度III级者由38.46%(5/13)降至22.22%(2/9)。
  • CPIS日均下降0.5分(P<0.01),氧合指数日均升高23.3 mmHg、动脉血氧分压日均升高12.6 mmHg(均P<0.01)。
  • 使用7天后Cst由40.9(37.5,50.0)mL/cmH2O升至55.6(50.0,58.0)mL/cmH2O,气道阻力由12.0(10.0,13.0)cmH2O×L-1×s-1降至9.6(6.9,10.5)cmH2O×L-1×s-1,DP由11.0(10.0,15.0)cmH2O降至9.0(9.0,12.0)cmH2O(均P<0.01)。
  • 治疗期间未见新发肺不张,患者未诉明显不适,心率、收缩压、舒张压及平均动脉压无实质性变化,无治疗相关不良事件。

适用人群与场景

  • 2022年4月至2023年5月中山大学附属第一医院重症医学科收治的有创机械通气并接受线上机械性吸呼气辅助排痰的患者,共13例,均为男性、呼吸衰竭,主要病因为颈髓损伤/高位截瘫(38.46%)。

处置流程与药物剂量

  • 对有创机械通气患者使用线上机械性吸呼气辅助排痰,并在使用第1、2、3、5、7天评估痰液黏度、氧合指数、通气功能与呼吸力学参数、临床肺部感染评分(CPIS)及生命体征。

研究设计与关键结果

  • 前瞻性观察性研究,纳入13例有创机械通气患者,均为男性、呼吸衰竭,主要病因为颈髓损伤/高位截瘫(38.46%)。
  • 使用前痰液黏度III级者占38.46%(5/13),使用7天后降至22.22%(2/9)。
  • 随使用时间延长,CPIS评分显著下降,日均下降0.5分(P<0.01)。
  • 氧合指数(PaO2/FiO2)日均升高23.3 mmHg(1 mmHg≈0.133 kPa),动脉血氧分压日均升高12.6 mmHg(均P<0.01)。
  • 使用7天后较基线,呼吸系统顺应性(Cst)显著升高[55.6(50.0,58.0)mL/cmH2O vs. 40.9(37.5,50.0)mL/cmH2O,P<0.01],气道阻力显著下降[9.6(6.9,10.5)cmH2O×L-1×s-1 vs. 12.0(10.0,13.0)cmH2O×L-1×s-1,P<0.01],驱动压(DP)显著下降[9.0(9.0,12.0)cmH2O vs. 11.0(10.0,15.0)cmH2O,P<0.01]。
  • 治疗期间未见新发肺不张,患者未诉明显不适,心率、收缩压、舒张压及平均动脉压治疗前后无实质性变化,无治疗相关不良事件。

证据类型、等级与局限

  • 前瞻性观察性研究,样本量13例,未报告局限性。

对床旁实践的改变

  • 作者认为,对有创机械通气患者联合使用线上机械性吸呼气辅助排痰可有效改善痰液性状、氧合及呼吸力学,患者耐受良好,无治疗相关不良事件,显示其有效性和安全性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the safety and clinical therapeutic effect of in-line mechanical in-exsufflation to assist sputum clearance in patients with invasive mechanical ventilation.

METHODS: A prospective observational study was conducted at the department of critical care medicine, the First Affiliated Hospital of Sun Yat-sen University from April 2022 to May 2023. Patients who were invasively ventilated and treated with in-line mechanical in-exsufflation to assist sputum clearance were enrolled. Baseline data were collected. Sputum viscosity, oxygenation index, parameters of ventilatory function and respiratory mechanics, clinical pulmonary infection score (CPIS) and vital signs before and after day 1, 2, 3, 5, 7 of use of the in-line mechanical in-exsufflation were assessed and recorded. Statistical analyses were performed by using generalized estimating equation (GEE).

RESULTS: A total of 13 invasively ventilated patients using in-line mechanical in-exsufflation were included, all of whom were male and had respiratory failure, with the main cause being cervical spinal cord injury/high-level paraplegia (38.46%). Before the use of the in-line mechanical in-exsufflation, the proportion of patients with sputum viscosity of grade III was 38.46% (5/13) and decreased to 22.22% (2/9) 7 days after treatment with in-line mechanical in-exsufflation. With the prolonged use of the in-line mechanical in-exsufflation, the patients' CPIS scores tended to decrease significantly, with a mean decrease of 0.5 points per day (P < 0.01). Oxygenation improved significantly, with the oxygenation index (PaO2/FiO2) increasing by a mean of 23.3 mmHg (1 mmHg ≈ 0.133 kPa) per day and the arterial partial pressure of oxygen increasing by a mean of 12.6 mmHg per day (both P < 0.01). Compared to baseline, the respiratory mechanics of the patients improved significantly 7 days after in-line mechanical in-exsufflation use, with a significant increase in the compliance of respiratory system (Cst) [mL/cmH2O (1 cmH2O ≈ 0.098 kPa): 55.6 (50.0, 58.0) vs. 40.9 (37.5, 50.0), P < 0.01], and both the airway resistance and driving pressure (DP) were significantly decreased [airway resistance (cmH2O×L-1×s-1): 9.6 (6.9, 10.5) vs. 12.0 (10.0, 13.0), DP (cmH2O): 9.0 (9.0, 12.0) vs. 11.0 (10.0, 15.0), both P < 0.01]. At the same time, no new lung collapse was observed during the treatment period. No significant discomfort was reported by patients, and there were no substantial changes in heart rate, systolic blood pressure, diastolic blood pressure, and mean arterial pressure before and after the in-line mechanical in-exsufflation treatment.

CONCLUSIONS: The combined use of the in-line mechanical in-exsufflation to assist sputum clearance in patients on invasive mechanical ventilation can effectively improve sputum characteristics, oxygenation and respiratory mechanics. The in-line mechanical in-exsufflation was well tolerated by the patients, with no treatment-related adverse events, which demonstrated its effectiveness and safety.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Wei B, Zheng H, Si X, et al. [An observational study on the clinical effects of in-line mechanical in-exsufflation in mechanical ventilated patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 40201997. doi:10.3760/cma.j.cn121430-20241008-00821

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。